The role partners with Legal, Procurement, Finance, Clinical, Research, Human Resources, and other business teams to ensure requests are complete, approvals are obtained, CLM records are accurate, and stakeholders receive timely, helpful service. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.